期刊文献+

Cyclin D1和p16在肥大乳房腺体组织中的表达及意义 被引量:1

The expression and significance of Cyclin D1 and p16 in the tissue of mammary hypertrophy
下载PDF
导出
摘要 目的:探讨Cyclin D1以及p16蛋白在肥大乳房乳腺组织中的表达及意义。方法:采用免疫组化SP法,检测35例肥大乳房及16例正常体积乳房乳腺组织中cyclinD1及p16蛋白的表达情况及相互联系。结果:35例肥大乳房腺体组织中Cyclin D1蛋白阳性表达率51.4%(18/35),16例正常体积乳房标本腺体组织中无一例Cyclin D1呈阳性表达(0/16),两组间比较差异有统计学意义(P<0.05)。肥大乳房组腺体组织中p16蛋白阴性表达率为77.2%(27/35),正常体积乳房腺体组织中阴性率为31.3%(5/16),两组间比较差异有统计学意义(P<0.05)。在Cyclin D1阳性表达的18例样本中,p16阴性表达者17例,阳性表达者1例,Cyclin D1阴性表达的17例样本中,p16阴性表达者10例,阳性表达者7例。Pearson相关性分析显示,Cyclin D1与p16的表达呈负相关(P<0.05)。结论:①Cyclin D1在肥大乳房腺体中呈高表达,p16呈低表达,提示其可能参与了肥大乳房的发生和发展;②Cyclin D1和p16在肥大乳房组织中的表达呈负相关,提示二者存在着一定的调控关系。 Objective To investigate the expression of the Cyclin D1 and p16 in the tissue of mastoplasia. Methods The alteration of cyciin D1 and p16 in 35 cases within the tissue of mastoplasia and 16 cases within the normal breast were detected using highly sensitive SP immunohistochemistry method. Results The rate of the positive expression of CyclinD1 in mammary hypertrophy group was 51.4% (18/35), no positive expression of CyclinD1 in the normal mammary group was detected. There was obvious significant between the two groups in a statistics basis (P〈0.05). While in mammary hypertrophy group the rate of the negative expression of p16 was 77.2% (27/35). There was also obvious significant between the two groups in a statistics basis (P〈0.05). In mammary hypertrophy group, within the 18 cases of positive expression of CyclinD1, the negative expression of p16 is 17cases, while within the 17 cases of negative expression of CyclinD1, the negative expression of p16 is 10 cases. There exists negative correlation between CyclinD1 and p16 in mammary hypertrophy group. Conclusions ~There were over expression of CyclinD1 and decreased expression of p16 within mammary gland in mammary hypertrophy which may be involved in the occurrence of mammary hypertrophy. ~Increased expression of CyclinD1 may be in certain relation with the decreased expression of p16 in the development of mammary hypertrophy.
出处 《中国美容医学》 CAS 2010年第10期1481-1484,共4页 Chinese Journal of Aesthetic Medicine
基金 湖北省科技攻关项目资助(项目编号:2005324)
关键词 细胞周期素D1 P16 肥大乳房 cyclin D1 p16 mammary hypermastia
  • 相关文献

参考文献8

二级参考文献66

  • 1秦映芬,沈寒蕾,黄松,韦敏怡.巨乳症的临床与病理学观察[J].临床与实验病理学杂志,2004,20(3):292-294. 被引量:14
  • 2孙家明,乔群,戚可名.肥大乳房和小乳房乳腺组织中雌激素受体的表达[J].中华整形外科杂志,2004,20(6):415-417. 被引量:14
  • 3吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 4Taketani Y, Oka T. Possible physiological role of epidermal growth factor in the development of the mouse mammary gland during pregnancy[J]. FEBS Lett, 1983, 152(2):256-261.
  • 5Taketani Y,Oka T. Biological action of epidermal growth factor and its fimctional receptors in normal mammary epithelial cells [J].Proc Natl Acad Sci U.S.A., 1983,80(9):2647-2650.
  • 6Sigurdson LJ, Kirkland SA. Breast volume determination in breast hypertrophy:anaccurate method using two anthropomorphic measurements[J]. Plast Reconstr Surg,2006,118(2): 313-320.
  • 7Morimoto T, Komaki K, Mori T, et al. Juvenile gigantomastia: report of a case[J]. Surg Today,1993,23 (3): 260-264.
  • 8Noczynska A, Wasikowa R, Myczkowski T. Hypersensitivity of estrogen receptors as a cause of gigantomasty in two girls [J]. Pol Merkuriusz Lek,2001,11 (66): 507-509.
  • 9WangJF, Park IW, Groopman JE. Stromal cell-derived factorlalpha stimulates tyrosine phosphorylation of multiple focal adhesion tyrosine proteins and induces migration of hematopoietic progenitor cells; roles of phosphoinositide-3 kinase and protein kinase C [J]. Blood,2000,95(8):2505-2513.
  • 10Ignar-Trowbridge DM,Teng CT. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element[J]. Mol Endocrinol,1993,7(8):992-998.

共引文献45

同被引文献9

  • 1Jin B J, Min H J,Jeong J H,et al. Expression of EGFRand microvessel density in middle ear cholesteatoma[ J].Clin Exp Otorhinolaryngol, 2011,4(2) :67-71.
  • 2RaffaS,Leone L, ScrofaniC,etal. Cholesteatoma-asso-ciated fibroblasts modulate epithelial growth and differenti-ation through KGF/FGF7 secretion [ J]. Histochem CellBiol, 2012,138(2) :251-269.
  • 3Hamajima Y, Komori M, Preciado D A,et al. The roleof inhibitor of DNA-binding (Idl) in hyperproliferationof keratinocytes : The pathological basis for middle earcholesteatoma from chronic otitis media [ J]. Cell Prolif,2010,43(5) :457463.
  • 4Yamamoto-Fukuda T, Hishikawa Y, Shibata Y,et al.Pathogenesis of middle ear cholesteatoma : A new modelof experimentally induced cholesteatoma in Mongoliangerbils[ J]. Am J Pathol, 2010,176(6) :2602-2606.
  • 5Klenke C,Janowski S, Borck D, et al. Identification ofnovel cholesteatoma-related gene expression signatures u-sing full-genome microarrays [ J]. PLoS One,2012,7(12) :e52718.
  • 6Sasaki H, Huang C C. Expression of cytokeratins 13 and16 in middle ear cholesteatoma [ J]. Otolaryngol HeadNeck Surg, 1994, 110(3):310-317.
  • 7Fu M,Wang C,Li Z, et al. Minireview: CyclinDl ;normal and abnormal functions [ J]. Endocrinology,2004, 145(12) ;5439-5447.
  • 8Coqueret O. Linking Cyclins to transcription control[ J].Gene, 2002, 299(1-2) :35-55.
  • 9罗赛,郝立君,于冬梅,李颖,刘莺.瘢痕疙瘩成纤维细胞p16、cyclinD1、CDK4、Rb的表达差异及其意义探讨[J].中国美容整形外科杂志,2008,19(3):171-174. 被引量:3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部